Literature DB >> 21234654

Angiotensin II type 1 receptor gene polymorphism and telomere shortening in essential hypertension.

Wael Farrag1, Manal Eid, Sherien El-Shazly, Manal Abdallah.   

Abstract

Several genetic studies were carried out among hypertensive patients to assess allelic association at the 1166 position of the 3' untranslated region of angiotensin II type 1 receptor gene. In addition, attempts have also been made to find out whether telomere length attrition is associated with hypertension. The main aim of this study was to examine the association of A1166C polymorphism of angiotensin II type 1 receptor and telomere length with essential hypertension in Egyptian people. Angiotensin II type 1 genotyping and relative telomere length were investigated by PCR in 40 patients of essential hypertension and 15 healthy controls. The homozygous AA1166 allele frequency was 92.8% among the studied subjects. There was no intergroup variation in A allele frequency in normotensive group. The frequency of homozygous A allele was significantly higher in hypertensive than normotensive subjects (97.5 and 80%, respectively) with higher frequencies in male patients. The average telomere length ratio was significantly shorter in hypertensive than in normal subjects (1.08 ± 0.3 and 1.54 ± 0.18, respectively). No correlation was observed between telomere length ratio and body mass index. This study suggests that the homozygous A1166 allele of angiotensin II type 1 and short telomeres may be predisposing factors for essential hypertension in Egyptians and may be involved in the pathogenesis of the disease. Further strategies for treating high-risk patients could result in prevention or delay of end organ damage.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21234654     DOI: 10.1007/s11010-010-0706-0

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  26 in total

1.  Mapping of a major locus that determines telomere length in humans.

Authors:  Mariuca Vasa-Nicotera; Scott Brouilette; Massimo Mangino; John R Thompson; Peter Braund; Jenny-Rebecca Clemitson; Andrea Mason; Clare L Bodycote; Stuart M Raleigh; Edward Louis; Nilesh J Samani
Journal:  Am J Hum Genet       Date:  2004-11-01       Impact factor: 11.025

2.  Molecular cloning, sequence analysis and expression of a cDNA encoding human type-1 angiotensin II receptor.

Authors:  R Takayanagi; K Ohnaka; Y Sakai; R Nakao; T Yanase; M Haji; T Inagami; H Furuta; D F Gou; M Nakamuta
Journal:  Biochem Biophys Res Commun       Date:  1992-03-16       Impact factor: 3.575

3.  Evidence for involvement of the type 1 angiotensin II receptor locus in essential hypertension.

Authors:  K Kainulainen; M Perola; J Terwilliger; J Kaprio; M Koskenvuo; A C Syvänen; E Vartiainen; L Peltonen; K Kontula
Journal:  Hypertension       Date:  1999-03       Impact factor: 10.190

4.  Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction.

Authors:  Tohru Minamino; Hideaki Miyauchi; Toshihiko Yoshida; Yasuo Ishida; Hideo Yoshida; Issei Komuro
Journal:  Circulation       Date:  2002-04-02       Impact factor: 29.690

Review 5.  Polymorphism in angiotensin II receptor genes and hypertension.

Authors:  Bruno Baudin
Journal:  Exp Physiol       Date:  2005-01-07       Impact factor: 2.969

Review 6.  Angiotensin-converting enzyme 2: implications for blood pressure and kidney disease.

Authors:  Julie R Ingelfinger
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-01       Impact factor: 2.894

7.  Association between oxidative DNA damage and telomere shortening in circulating endothelial progenitor cells obtained from metabolic syndrome patients with coronary artery disease.

Authors:  Mamoru Satoh; Yuh Ishikawa; Yuji Takahashi; Tomonori Itoh; Yoshitaka Minami; Motoyuki Nakamura
Journal:  Atherosclerosis       Date:  2007-11-05       Impact factor: 5.162

Review 8.  Molecular biology of angiotensin II receptors: an overview.

Authors:  T Inagami; D F Guo; Y Kitami
Journal:  J Hypertens Suppl       Date:  1994-12

9.  Hypertension prevalence, awareness, treatment, and control in Egypt. Results from the Egyptian National Hypertension Project (NHP). NHP Investigative Team.

Authors:  M M Ibrahim; H Rizk; L J Appel; W el Aroussy; S Helmy; Y Sharaf; Z Ashour; H Kandil; E Roccella; P K Whelton
Journal:  Hypertension       Date:  1995-12       Impact factor: 10.190

10.  Telomere length trajectory and its determinants in persons with coronary artery disease: longitudinal findings from the heart and soul study.

Authors:  Ramin Farzaneh-Far; Jue Lin; Elissa Epel; Kyle Lapham; Elizabeth Blackburn; Mary A Whooley
Journal:  PLoS One       Date:  2010-01-08       Impact factor: 3.240

View more
  11 in total

Review 1.  The impact of hypertension on leukocyte telomere length: a systematic review and meta-analysis of human studies.

Authors:  M L Tellechea; C J Pirola
Journal:  J Hum Hypertens       Date:  2016-06-30       Impact factor: 3.012

Review 2.  Telomere shortening and Alzheimer's disease.

Authors:  Zhiyou Cai; Liang-Jun Yan; Anna Ratka
Journal:  Neuromolecular Med       Date:  2012-11-16       Impact factor: 3.843

3.  Leukocyte telomere length and ideal cardiovascular health in American Indians: the Strong Heart Family Study.

Authors:  Hao Peng; Mihriye Mete; Sameer Desale; Amanda M Fretts; Shelley A Cole; Lyle G Best; Jue Lin; Elizabeth Blackburn; Elisa T Lee; Barbara V Howard; Jinying Zhao
Journal:  Eur J Epidemiol       Date:  2016-09-22       Impact factor: 8.082

4.  Telomerase activation in the treatment of aging or degenerative diseases: a systematic review.

Authors:  P Prieto-Oliveira
Journal:  Mol Cell Biochem       Date:  2020-10-01       Impact factor: 3.396

5.  Genetic factors contributing to hypertension in African-based populations: A systematic review and meta-analysis.

Authors:  Yandiswa Y Yako; Eric V Balti; Tandi E Matsha; Anastase Dzudie; Deirdre Kruger; Eugene Sobngwi; Charles Agyemang; Andre P Kengne
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-03-09       Impact factor: 3.738

6.  Both in vitro T cell proliferation and telomere length are decreased, but CD25 expression and IL-2 production are not affected in aged men.

Authors:  Froylan Albarrán-Tamayo; Blanca Murillo-Ortiz; Roberto González Amaro; Sergio López Briones
Journal:  Arch Med Sci       Date:  2019-09-04       Impact factor: 3.318

7.  Angiotensin II type 1 receptor A1166C gene polymorphism and essential hypertension in Calabar and Uyo cities, Nigeria.

Authors:  Mary Esien Kooffreh; Chiaka Ijeoma Anumudu; Roseline Duke; Elza Cletus Okpako; P Lava Kumar
Journal:  Indian J Hum Genet       Date:  2013-04

8.  Association of angiotensin II type 1 receptor (A1166C) gene polymorphism and its increased expression in essential hypertension: a case-control study.

Authors:  Sudhir Chandra; Rajiv Narang; Vishnubhatla Sreenivas; Jagriti Bhatia; Daman Saluja; Kamna Srivastava
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

9.  Effect of vegetable consumption on the association between peripheral leucocyte telomere length and hypertension: a case-control study.

Authors:  Fuzhi Lian; Jinquan Wang; Xianhong Huang; Yinyin Wu; Yifei Cao; Xiaohua Tan; Xianrong Xu; Yu Hong; Lei Yang; Xiang Gao
Journal:  BMJ Open       Date:  2015-11-11       Impact factor: 2.692

10.  Shorter Leukocyte Telomere Length coupled with lower expression of Telomerase Genes in patients with Essential Hypertension.

Authors:  Guanghui Cheng; Lina Wang; Mingkai Dai; Fengtao Wei; Dawei Xu
Journal:  Int J Med Sci       Date:  2020-08-01       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.